Sign in
Companies / MRK vs VTRS

MRK vs VTRS: Merck and Viatris

Pharmaceuticals
Compare more companies

Merck (MRK) reported $65.0B in revenue against a 28.1% net margin, while Viatris (VTRS) reported $14.3B at a -24.6% net margin, most recently.

MetricMRKVTRS
Revenue$65.0B$14.3B
Net Income$18.3B$-3.5B
Gross Margin74.8%35.1%
Operating Margin—-18.6%
EPS (Diluted)$7.28$-3.00
Free Cash Flow$12.4B$1.9B
Total Debt$49.3B$14.4B
P/E Ratio14.5×n/m
P/B Ration/mn/m
Stock Price$147.90$19.00
Free: last 5 years
Fiscal yearFY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
MRK Revenue•••••••••••••••$48.7B$59.3B$60.1B$64.2B$65.0B
VTRS Revenue•••••••••••••••$17.9B$16.3B$15.4B$14.7B$14.3B

More on MRK

More on VTRS

Other comparisons